Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Wright

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Aerospace Medicine|July 1, 1973
Multiday exposure of men to high nitrogen pressure and increased airway resistance at natural expired oxygen tension: a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at 4.0 atmospheres absolute pressureC J Lambertsen, W B Wright
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1971
An evaluation of surgical interruption and spontaneous return of the systemic arterial circulation of the lungW B Wright, P Berg, Y Seki
Journal of the Chemical Society|March 19, 2010
The catechins of green teaA E BRADFIELD, M PENNY, W B WRIGHT
British Medical Journal|June 3, 1978
Ventilatory function in Parkinson's diseaseA D Mehta, W B Wright, B J Kirby
Age and Ageing|August 1, 1975
The Exe Vale joint psycho-geriatric assessment unit (Hallett Clinic)G E Langley, W B Wright, R R Sowden, et al.
Journal of Medicinal Chemistry|October 1, 1978
Derivatives of 1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione as anxiolytic agentsW B Wright, H J Brabander, E N Greenblatt, et al.
Journal of Medicinal Chemistry|December 1, 1987
Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-onesW B Wright, A S Tomcufcik, P S Chan, et al.
Journal of Medicinal Chemistry|April 1, 1980
Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agentsW B Wright, E N Greenblatt, I P Day, et al.
Aerospace Medicine|July 1, 1973
Pulmonary function studies during a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at pressure equivalent to 100 FSW (4 ATA)W B Wright, A B Fisher, P L Hendricks, et al.
Journal of Medicinal Chemistry|June 1, 1987
Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitorsJ B Press, W B Wright, P S Chan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Aerospace Medicine|July 1, 1973
Multiday exposure of men to high nitrogen pressure and increased airway resistance at natural expired oxygen tension: a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at 4.0 atmospheres absolute pressureC J Lambertsen, W B Wright
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1971
An evaluation of surgical interruption and spontaneous return of the systemic arterial circulation of the lungW B Wright, P Berg, Y Seki
Journal of the Chemical Society|March 19, 2010
The catechins of green teaA E BRADFIELD, M PENNY, W B WRIGHT
British Medical Journal|June 3, 1978
Ventilatory function in Parkinson's diseaseA D Mehta, W B Wright, B J Kirby
Age and Ageing|August 1, 1975
The Exe Vale joint psycho-geriatric assessment unit (Hallett Clinic)G E Langley, W B Wright, R R Sowden, et al.
Journal of Medicinal Chemistry|October 1, 1978
Derivatives of 1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione as anxiolytic agentsW B Wright, H J Brabander, E N Greenblatt, et al.
Journal of Medicinal Chemistry|December 1, 1987
Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-onesW B Wright, A S Tomcufcik, P S Chan, et al.
Journal of Medicinal Chemistry|April 1, 1980
Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agentsW B Wright, E N Greenblatt, I P Day, et al.
Aerospace Medicine|July 1, 1973
Pulmonary function studies during a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at pressure equivalent to 100 FSW (4 ATA)W B Wright, A B Fisher, P L Hendricks, et al.
Journal of Medicinal Chemistry|June 1, 1987
Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitorsJ B Press, W B Wright, P S Chan, et al.
Pageof 4